Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  DHAKA STOCK EXCHANGE LTD  >  Square Pharmaceuticals Ltd.    SQURPHARMA   BD0473SQPH00

SQUARE PHARMACEUTICALS LTD.

(SQURPHARMA)
  Report  
End-of-day quote. End-of-day quote DHAKA STOCK EXCHANGE LTD - 12/12
190 BDT   -0.05%
 SummaryChartsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Dhaka Stock Exchange Ltd
12/08/2019 12/09/2019 12/10/2019 12/11/2019 12/12/2019 Date
198.6 191.1 187.3 190.1 190 Last
224684 461529 661677 334697 491994 Volume
-0.60% -3.78% -1.99% +1.49% -0.05% Change
Financials (BDT)
Sales 2020 50 082 M
EBIT 2020 15 893 M
Net income 2020 -
Debt 2020 -
Yield 2020 2,71%
Sales 2021 56 685 M
EBIT 2021 18 261 M
Net income 2021 -
Debt 2021 -
Yield 2021 3,20%
P/E ratio 2020 -
P/E ratio 2021 -
Capi. / Sales2020 3,20x
Capi. / Sales2021 2,83x
Capitalization 160 B
More Financials
Company
SQUARE Pharmaceuticals Limited is a pharmaceutical company. The Company offers products for various therapeutic classes, such as alimentary preparations, anesthetics, anti-arthritis supplement, anti-asthma, anti-epileptic, anti-erectile dysfunction agent, anti-obesity preparation, antiallergy... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on SQUARE PHARMACEUTICALS LTD

- No features available -

More news
News in other languages on SQUARE PHARMACEUTICALS LTD

- No features available -

More news
Sector news : Pharmaceuticals - NEC
08:01aBIOGEN : to End Development of Gosuranemab in Progressive Supranuclear Palsy
DJ
07:34aNOVARTIS : Beovu Eye Disease Drug Nears Marketing Approval With CHMP Recommendat..
DJ
07:23aGENENTECH : Tecentriq/Cotellic/Zelboraf Combo Study Meets Primary Endpoint
DJ
12/12PFIZER : Says FDA Approves Xeljanz XR Extended-Release Tablets to Treat Ulcerati..
DJ
12/12Amneal Shares Up Nearly 50% on FDA Nod for NuvaRing Generic
DJ
More sector news : Pharmaceuticals - NEC
Chart SQUARE PHARMACEUTICALS LTD.
Duration : Period :
Square Pharmaceuticals Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 293,37  BDT
Last Close Price 190,00  BDT
Spread / Highest target 71,2%
Spread / Average Target 54,4%
Spread / Lowest Target 37,5%
EPS Revisions
Managers
NameTitle
Tapan M. A. Chowdhury CEO, Managing Director & Director
Samuel S. Chowdhury Chairman
Mohammed Mizanur Rahman Executive Director-Operations
Mohammed Zahangir Alam Bhuiyan Chief Financial Officer
Mahbubur Rahman Head-Engineering
Sector and Competitors
1st jan.Capitalization (M$)
SQUARE PHARMACEUTICALS LTD.-25.20%1 889
JOHNSON & JOHNSON9.24%371 989
ROCHE HOLDING AG24.22%261 794
MERCK AND COMPANY17.22%228 044
PFIZER-11.71%213 285
NOVARTIS22.85%209 621